Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (CT, MRI, PET/SPECT, Multi-modal, Optical, Ultrasound, Photoacoustic (PAT), Reagents, Services), By Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Preclinical Imaging Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Technological Advancements
3.4.1.2. Growing Number of Investments and Funding in Research and Development
3.4.2. Market restraint analysis
3.4.2.1. Strict regulatory framework
3.5. Preclinical Imaging Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
第四章。临床前成像市场:产品imates & Trend Analysis
4.1. Definitions and Scope
4.1.1. CT Imaging
4.1.2. MRI Imaging
4.1.3. PET/SPECT Imaging
4.1.4. Multi-modal Imaging
4.1.5. Optical Imaging
4.1.6. Ultrasound Imaging
4.1.7. Photoacoustic Imaging
4.1.8. Reagents
4.1.9. Services
4.2. Product Market Share, 2017 & 2030
4.3. Segment Dashboard
4.4. Preclinical Imaging Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
4.5.1. CT imaging
4.5.1.1. CT imaging market estimates and forecast 2017 to 2030 (USD Million)
4.5.2. MRI imaging
4.5.2.1. MRI imaging market estimates and forecast 2017 to 2030 (USD Million)
4.5.3. PET/SPECT imaging
4.5.3.1. PET/SPECT imaging market estimates and forecast 2017 to 2030 (USD Million)
4.5.4. Multi-modal imaging
4.5.4.1. Multi-modal imaging market estimates and forecast 2017 to 2030 (USD Million)
4.5.5. Optical imaging
4.5.5.1. Optical imaging market estimates and forecast 2017 to 2030 (USD Million)
4.5.6. Ultrasound imaging
4.5.6.1. Ultrasound imaging market estimates and forecast 2017 to 2030 (USD Million)
4.5.7. Photoacoustic imaging
4.5.7.1. Photoacoustic imaging market estimates and forecast 2017 to 2030 (USD Million)
4.5.8. Reagents
4.5.8.1. Reagents imaging market estimates and forecast 2017 to 2030 (USD Million)
4.5.9. Services
4.5.9.1. Services market estimates and forecast 2017 to 2030 (USD Million)
Chapter 5. Preclinical Imaging Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Research and Development
5.1.2. Drug Discovery
5.2. Product Market Share, 2017 & 2030
5.3. Segment Dashboard
5.4. Preclinical Imaging Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
5.5.1. Research and Development
5.5.1.1. Research and development market estimates and forecast 2017 to 2030 (USD Million)
5.5.2. Drug delivery
5.5.2.1. Drug delivery market estimates and forecast 2017 to 2030 (USD Million)
Chapter 6. Preclinical Imaging Market: End use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Biotech Companies
6.1.2. Pharmaceutical companies
6.1.3. Research institutes
6.2. Product Market Share, 2017 & 2030
6.3. Segment Dashboard
6.4. Preclinical Imaging Market by Product Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
6.5.1. Biotech companies
6.5.1.1. Biotech companies market estimates and forecast 2017 to 2030 (USD Million)
6.5.2. Pharmaceutical companies
6.5.2.1. Pharmaceutical companies market estimates and forecast 2017 to 2030 (USD Million)
6.5.3. Research institutes
6.5.3.1. Research institutes market estimates and forecast 2017 to 2030 (USD Million)
Chapter 7. Preclinical Imaging Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2020 & 2028
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2017 to 2030:
7.7. North America
7.7.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.8. Europe
7.8.1. UK
7.8.1.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.8.3. France
7.8.3.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.9. Asia Pacific
7.9.1. Japan
7.9.1.1. Market estimates and forecast, 2017 - 2028 (Volume, Thousand)
7.9.2. China
7.9.2.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.9.3. India
7.9.3.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.9.4. South Korea
7.9.4.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.11. MEA
7.11.1. Saudi Arabia
7.11.1.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.11.2. South Africa
7.11.2.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2017 - 2028 (Value & Volume)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2020
8.3.4. Bruker Corporation
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Siemens Healthineers AG
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. GE Healthcare
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. TriFoil Imaging
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. PerkinElmer, Inc.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9.富士FILM SonoSite, Inc.,
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Mediso Ltd.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Agilent Technologies
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. MR Solutions
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. MILabs B.V.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Molecubes
8.3.14.1.公司现rview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 3 North America Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 4 North America Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 5 North America Preclinical Imaging market, by region, 2017 - 2030 (USD Million)
Table 6 U.S. Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 7 U.S. Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 8 U.S. Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 9 Canada Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 10 Canada Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 11 Canada Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 12 Europe Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 13 Europe Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 14 Europe Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 15 Europe Preclinical Imaging market, by region, 2017 - 2030 (USD Million)
Table 16 Germany Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 17 Germany Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 18 Germany Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 19 UK Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 20 UK Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 21 UK Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 22 France Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 23 France Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 24 France Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 25 Italy Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 26 Italy Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 27 Italy Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 28 Spain Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 29 Spain Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 30 Spain Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 31 APAC Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 32 APAC Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 33 APAC Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 34 APAC Preclinical Imaging market, by region, 2017 - 2030 (USD Million)
Table 35 Japan Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 36 Japan Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 37 Japan Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 38 China Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 39 China Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 40 China Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 41 India Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 42 India Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 43 India Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 44 South Korea Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 45 South Korea Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 46 South Korea Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 47 Latin America Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 48 Latin America Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 49 Latin America Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 50 Latin America Preclinical Imaging market, by region, 2017 - 2030 (USD Million)
Table 51 Brazil Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 52 Brazil Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 53 Brazil Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 54 Mexico Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 55 Mexico Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 56 Mexico Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 57 Argentina Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 58 Argentina Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 59 Argentina Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 60 Middle East and Africa Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 61 Middle East and Africa Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 62 Middle East and Africa Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 63 Middle East and Africa Preclinical Imaging market, by region, 2017 - 2030 (USD Million)
Table 64 South Africa Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 65 South Africa Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 66 South Africa Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 67 Saudi Arabia Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 68 Saudi Arabia Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 69 Saudi Arabia Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)
Table 70 UAE Preclinical Imaging market, by product, 2017 - 2030 (USD Million)
Table 71 UAE. Preclinical Imaging market, by application, 2017 - 2030 (USD Million)
Table 72 UAE Preclinical Imaging market, by end use, 2017 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
图10 Value-chain-based分级和预测
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Preclinical Imaging market: market outlook
Fig. 14 Preclinical Imaging market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Preclinical Imaging market driver impact
Fig. 20 Preclinical Imaging market restraint impact
Fig. 21 Preclinical Imaging market strategic initiatives analysis
Fig. 22 Preclinical Imaging market: product movement analysis
Fig. 23 Preclinical Imaging market: product outlook and key takeaways
Fig. 24 CT imaging market estimates and forecast, 2017 - 2030
图25 MRI成像市场估计和预测,2017 - 2030
Fig. 26 PET/SPECT imaging market estimates and forecast, 2017 - 2030
Fig. 27 Multi-modal imaging market estimates and forecast, 2017 - 2030
Fig. 28 Optical imaging market estimates and forecast, 2017 - 2030
Fig. 29 Ultrasound imaging market estimates and forecast, 2017 - 2030
Fig. 30 Photoacoustic imaging market estimates and forecast, 2017 - 2030
Fig. 31 Reagents market estimates and forecast, 2017 - 2030
Fig. 32 Services market estimates and forecast, 2017 - 2030
Fig. 33 Preclinical Imaging market: application movement analysis
Fig. 34 Preclinical Imaging market: application outlook and key takeaways
Fig. 35 Research and development market estimates and forecast, 2017 - 2030
Fig. 36 Drug Discovery market estimates and forecast, 2017 - 2030
Fig. 37 Preclinical Imaging market: end use movement analysis
Fig. 38 Preclinical Imaging market: end use outlook and key takeaways
Fig. 39 Biotech companies market estimates and forecast, 2017 - 2030
Fig. 40 Pharmaceutical companies market estimates and forecast, 2017 - 2030
Fig. 41 Research institutes market estimates and forecast, 2017 - 2030
Fig. 42 Global Preclinical Imaging market: regional movement analysis
Fig. 43 Global Preclinical Imaging market: regional outlook and key takeaways
Fig. 44 Global market share and leading players
Fig. 45 North America market share and leading players
Fig. 46 Europe market share and leading players
Fig. 47 Asia Pacific market share and leading players
Fig. 48 Latin America market share and leading players
Fig. 49 Middle East & Africa market share and leading players
Fig. 50 North America: SWOT
Fig. 51 Europe SWOT
Fig. 52 Asia Pacific SWOT
Fig. 53 Latin America SWOT
Fig. 54 MEA SWOT
Fig. 55 North America, by country
Fig. 56 North America
Fig. 57 North America market estimates and forecast, 2017 - 2030
Fig. 58 U.S.
Fig. 59 U.S. market estimates and forecast, 2017 - 2030
Fig. 60 Canada
Fig. 61 Canada market estimates and forecast, 2017 - 2030
Fig. 62 Europe
Fig. 63 Europe. market estimates and forecast, 2017 - 2030
Fig. 64 UK
Fig. 65 UK market estimates and forecast, 2017 - 2030
Fig. 66 Germany
Fig. 67 Germany market estimates and forecast, 2017 - 2030
图68年法国
Fig. 69 France market estimates and forecast, 2017 - 2030
Fig. 70 Italy
Fig. 71 Italy market estimates and forecast, 2017 - 2030
Fig. 72 Spain
Fig. 73 Spain market estimates and forecast, 2017 - 2030
Fig. 74 Asia Pacific
Fig. 75 Asia Pacific market estimates and forecast, 2017 - 2030
Fig. 76 Japan
Fig. 77 Japan market estimates and forecast, 2017 - 2030
Fig. 78 China
Fig. 79 China market estimates and forecast, 2017 - 2030
Fig. 80 India
Fig. 81 India market estimates and forecast, 2017 - 2030
Fig. 82 South Korea
Fig. 83 South Korea market estimates and forecast, 2017 - 2030
Fig. 84 Latin America
Fig. 85 Latin America market estimates and forecast, 2017 - 2030
Fig. 86 Brazil
Fig. 87 Brazil market estimates and forecast, 2017 - 2030
Fig. 88 Mexico
Fig. 89 Mexico market estimates and forecast, 2017 - 2030
Fig. 90 Argentina
Fig. 91 Argentina market estimates and forecast, 2017 - 2030
Fig. 92 Middle East and Africa
Fig. 93 Middle East and Africa. market estimates and forecast, 2017 - 2030
Fig. 94 South Africa
Fig. 95 South Africa market estimates and forecast, 2017 - 2030
Fig. 96 Saudi Arabia
Fig. 97 Saudi Arabia market estimates and forecast, 2017 - 2030
Fig. 98 UAE
Fig. 99 UAE market estimates and forecast, 2017 - 2030
Fig. 100 Participant categorization- Preclinical Imaging market
Fig. 101 Market share of key market players- Preclinical Imaging market